Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126706851 | 12670685 | 1 | I | 20150429 | 20160822 | 20160822 | EXP | CA-AMGEN-CANSP2015042116 | AMGEN | 42.00 | YR | A | F | Y | 0.00000 | 20160822 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126706851 | 12670685 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 126706851 | 12670685 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Unknown | UNK | 0 | ||||||||||
| 126706851 | 12670685 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | 162 MG, UNK | 0 | 162 | MG | ||||||||
| 126706851 | 12670685 | 4 | SS | LANTUS | INSULIN GLARGINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126706851 | 12670685 | 5 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 126706851 | 12670685 | 6 | SS | NOVOLIN GE TORONTO | INSULIN HUMAN | 1 | Unknown | UNK, 3 EVERY 1 DAY | 0 | ||||||||||
| 126706851 | 12670685 | 7 | C | RANITIDINE. | RANITIDINE | 1 | UNK | 0 | |||||||||||
| 126706851 | 12670685 | 8 | C | XELJANZ | TOFACITINIB CITRATE | 1 | UNK | 0 | |||||||||||
| 126706851 | 12670685 | 9 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126706851 | 12670685 | 10 | C | CELEBREX | CELECOXIB | 1 | UNK | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126706851 | 12670685 | 1 | Product used for unknown indication |
| 126706851 | 12670685 | 2 | Product used for unknown indication |
| 126706851 | 12670685 | 3 | Rheumatoid arthritis |
| 126706851 | 12670685 | 4 | Product used for unknown indication |
| 126706851 | 12670685 | 5 | Product used for unknown indication |
| 126706851 | 12670685 | 6 | Product used for unknown indication |
| 126706851 | 12670685 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126706851 | 12670685 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126706851 | 12670685 | Abasia | |
| 126706851 | 12670685 | Adverse drug reaction | |
| 126706851 | 12670685 | Arthralgia | |
| 126706851 | 12670685 | Condition aggravated | |
| 126706851 | 12670685 | Drug ineffective | |
| 126706851 | 12670685 | Headache | |
| 126706851 | 12670685 | Hypoaesthesia | |
| 126706851 | 12670685 | Lower respiratory tract infection | |
| 126706851 | 12670685 | Pharyngitis | |
| 126706851 | 12670685 | Toothache |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |